MOLECULAR MECHANISMS OF REGULATION OF GENE EXPRESSION AT HYPOXIA
DOI: http://dx.doi.org/10.30970/sbi.0701.267
Abstract
Hypoxia is one of powerful inducers of expression of a large group of genes, including genes which control glycolysis, angiogenesis and proliferation supportingcell surviving at low oxygen condition. However, in tumor cells hypoxia was observed at normal oxygen tension condition as a result of its decreased utilization. Moreover, hypoxia is an obligate component of malignant tumor growth and substantially controls glycolysis, angiogenesis and proliferation processes. Data concerning molecular mechanisms of activation of hypoxia inducible transcription factor HIF in cells at hypoxia and in malignant tumors, as well as its role of in the regulation of gene expressions have been analyzed. The mechanisms of interaction of the transcription factor HIF with specific hypoxic regulatory elements in the promoter region of genes activated by hypoxia were examined.
Keywords
Full Text:
PDF (Українська)References
1. Brahimi-Horn M.C., Berra E., Pouyssgur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends in Cellular Biology, 2001; 11: 32-36. | |
| |
2. Bertout J.A., Patel S.A., Simon M.C. The impact of O2 availability on human cancer. Nature Reviews Cancer, 2008; 8(12): 967-975. | |
| |
3. Brahimi-Horn M.C., Chiche J., Pouyssgur J. Hypoxia and cancer. Journal of Molecular Medicine, 2007; 85(12): 1301-1307. | |
| |
4. Hopfl G., Ogunshola O., Gassmann M. HIFs and tumors - causes and consequences. American Journal Physiology, 2004; 286(4): R608-R623. | |
| |
5. Arsham A.M., Plas D.R., Thompson C.B., Simon M.C. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Research, 2004; 64: 3500-3507. | |
| |
6. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cellular Death Differentiation, 2008; 15(4): 678-685. | |
| |
7. Brahimi-Horn M.C., Chiche J., Pouysségur J. Hypoxia signalling controls metabolic demand. Current Opinions in Cellular Biology, 2007; 19(2): 223-229. | |
| |
8. Vaupel P., Hockel M., Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxidants & Redox Signaling, 2007; 9(8): 1221-1235. | |
| |
9. Greijer A.E., van der Groep P., Kemming D. et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). Journal of Pathology, 2005; 206(3): 291-304. | |
| |
10. Minchenko D.О., Kubajchuk К.І., Hubenia О.V. et al. The effect of hypoxia and ischemic condition on the expression of VEGF genes in glioma U87 cells is dependent from ERN1 knockdown. Advances in Biological Chemistry, 2011; 2(2): 198-206. | |
| |
11. Kappler M., Taubert H., Schubert J. et al. The real face of HIF1α in the tumor process. Cell Cycle, 2012; 11(21): 3932-3936. | |
| |
12. Stoeltzing O., McCarty M.F., Wey J.S. et al. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. Journal of National Cancer Institute, 2004; 96(12): 946-956. | |
| |
13. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death and Differentiation, 2008; 15(4): 678-685. | |
| |
14. Chen Y., Zhang .L, Pan Y. et al. Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1alpha; and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer. International Journal of Molecular Sciences, 2012; 13(10): 13264-13274. | |
| |
15. Bertout J.A., Majmundar A.J., Gordan J.D. et al. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proceedings of the National Academy of Sciences of the U.S.A., 2009; 106(34): 14391-14396. | |
| |
16. Ratcliffe P.J., O'Rourke J.F., Maxwell P.H., Pugh C.W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. Journal of Experimental Biology, 1998; 201: 1153-1162. | |
| |
17. Uchida T., Rossignol F., Matthay M.A. et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor HIF-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. The Journal of Biological Chemistry, 2004; 279(15): 14871-14878. | |
| |
18. Stroka D.M., Burkhardt T., Desbaillets I. et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB Journal, 2001; 15(13): 2445-2453. | |
| |
19. Bilton R., Booker G.W. The subtle side to hypoxia inducible factor (HIFα) regulation. European Journal of Biochemistry, 2003; 270: 791-798. | |
| |
20. Cheng J.C., Klausen C., Leung P.C. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Letters, 2013; 329(2): 197-206. | |
| |
21. Kenneth N. S., Rocha S. Regulation of gene expression by hypoxia. Biochemical Journal, 2008; 414: 19-29. | |
| |
22. Semenza G.L., Jiang B.-H., Leung S.W. et al. Hypoxia response elements in the aldolase A, enolase 1 and lactate dehydrogenase A gene promoters contain essential binding sites for HIF-1. The Journal of Biological Chemistry, 1996; 27(51): 32529-32537. | |
| |
23. Minchenko A., Caro J. Regulation of endotelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element. Molecular and Cellular Biochemistry, 2000; 208(1): 53-62. | |
| |
24. Lee J.-W., Bae S.-H., Jeong J.-W. et al. Hypoxia-inducible factor (HIF-1)a: its protein stability and biological functions. Experimental and Molecular Medicine, 2004; 36(1): 1-12. | |
| |
25. Ke Q., Costa M. Hypoxia-inducible-factor-1 (HIF-1). Molecular Pharmacology, 2006; 70(5): 1469-1480. | |
| |
26. Koh M.Y., Spivak-Kroizman T.R., Powis G. HIF-1 regulation: not so easy come, easy go. Trends in Biochemical Sciences, 2008; 33(11): 526-533. | |
| |
27. Chun Y.S., Choi E., Yeo E.J. et al. A new HIF-1alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses. Journal of Cell Science, 2001; 114: 4051-4061. | |
| |
28. Chun Y.S., Choi E., Kim T.Y. et al. A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible-factor-1alpha gene. Biochemical Journal, 2002; 362: 71-79. | |
| |
29. Chun Y.S., Lee K.H., Choi E. et al. Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible-factor 1alpha isoform: implications for tumor promotion. Cancer Research, 2003; 63: 8700-8707. | |
| |
30. Semenza G.L. Oxygen-regulated transcription factors and their role in pulmonary disease. Respiratory Research, 2000; 1: 159-162. | |
| |
31. Kaur B., Khwaja F.W., Severson E.A. et al. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-Oncology, 2005; 7(2): 134-153. | |
| |
32. Makino Y., Cao R.H., Svensson K. et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature (London), 2001; 414: 550-554. | |
| |
33. Makino Y., Kanopka A., Wilson W.J. et al. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. The Journal of Biological Chemistry, 2002; 277: 32405-32408. | |
| |
34. Depping R., Hagele S., Wagner K.F. et al. A dominant-negative isoform of hypoxia-inducible factor-1 alpha specifically expressed in human testis. Biology of Reproduction, 2004; 71(1): 331-339. | |
| |
35. Wiesener M.S., Jurgensen J.S., Rosenberger C. et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB Journal, 2003; 17(2): 271-273. | |
| |
36. Hu C.J., Wang L.Y., Chodosh L.A. et al. Differential roles of hypoxia-inducible factor 1alpha (HIF-1a) and HIF-2a in hypoxic gene regulation. Molecular and Cellular Biology, 2003; 24: 936-9374. | |
| |
37. Sowter H.M., Raval R.R., Moore J.W. et al. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Research, 2003; 63(19): 6130-6134. | |
| |
38. Uchida T., Rossignol F., Matthay M.A. et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor HIF-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. The Journal of Biological Chemistry, 2004; 279(15):14871-14878. | |
| |
39. Lando D., Peet D.J., Whelan D.A. et al. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science, 2002; 295: 858-861. | |
| |
40. Ivan M., Haberberger T., Gervasi D.C. et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proceedings of the National Academy of Sciences of the U.S.A., 2002; 99(21): 13459-13464. | |
| |
41. Jaakkola P., Mole D.R., Tian Y.M. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2 - regulated prolyl hydroxylation. Science, 2001; 292: 468-471. | |
| |
42. Srinivas V., Leshchinsky I., Sang N. et al. Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. The Journal of Biological Chemistry, 2001; 276(25): 21995-21998. | |
| |
43. Minchenko A. G., Leshchinsky I., Opentanova I. L. et al. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. The Journal of Biological Chemistry, 2002; 277(8): 6183-6187. | |
| |
44. Minchenko O.H., Opentanova I.L., Minchenko D.O. et al. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 gene via hypoxia-inducible factor-1alpha activation. FEBS Letters, 2004; 576(1): 14-20. | |
| |
45. Bobarykina А.Y., Мінченко Д.О., Opentanova I.L. et al. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochimica Polonica, 2006; 53(4): 789-799. | |
| |
46. Бобарикіна А.Ю., Мінченко Д.О., Опентанова І.Л. та ін. Експресія мРНК HIF-1a, HIF-2a та VHL у різних лініях клітин при гіпоксії. Український біохімічний журнал, 2006; 78(2): 62-72. | |
| |
47. Mahon P.C., Hirota K., Semenza G.L. FIH 1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF 1 transcriptional activity. Genes & Development, 2001; 15: 2675-2686. | |
| |
48. Masson N., Ratcliffe P.J. HIF prolyl and asparaginyl hydroxylases in biological response to intracellular O2 levels. Journal of Cell Science, 2003; 116: 3041- 3049. | |
| |
49. Hewitson K.S., McNeill L.A., Riordan M.V. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. The Journal of Biological Chemistry, 2002; 277: 26351- 26355. | |
| |
50. Jaakkola P., Mole D.R., Tian Y.M. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2 - regulated prolyl hydroxylation. Science, 2001; 292: 468-471. | |
| |
51. Ivan M., Kondo Z.K., Yang H.F. et al. HIF-1α targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science, 2001; 292: 464-468. | |
| |
53. Appelhoff R.J., Tian Y-M., Raval R.R. Differential function of the prolyl hydroxylase PHD1, PHD2 and PHD3 in the regulation of hypoxia-inducible factor. The Journal of Biological Chemistry, 2004; 279(37): 38458-38465. | |
| |
53. Raur B.H., Durar V., Gottlieb E. Prolyl hydroxylases as regulators of cell metabolism. Biochemical Society Transactions, 2009; 37: 291-294. | |
| |
54. Kaelin W.G.Jr. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochemical and Biophysical Research Communications, 2005; 338(1): 627-638. | |
| |
55. Min J.-H., Yang H., Ivan M., Gertler F. Structure of a HIF-1a-pVHL complex: hydroxyprolyne recognition in signalling. Science, 2002: 296: 1886-1889. | |
| |
56. Lancaster D.E., McNeill L.A., McDonough M.A. et al. Disruption of dimerization and substrate phosphorylation inhibit factor inhibiting hypoxia-inducible factor (FIH) activity. Biochemical Journal, 2004: 383: 429-437. | |
| |
57. Lee C., Kim S.J., Jeong D.G. et al. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. The Journal of Biological Chemistry, 2003; 278(9): 7558-7563. | |
| |
58. Taylor M.S. Characterization and comparative analysis of the EGLN gene family. Gene, 2001; 275: 125-132. | |
| |
59. Elkis J.M., Hewitson K.S., McNeil L.A. et al. Structure of factor inhibiting hypoxia-inducible factors (HIF) reveals mechanism of oxidative modification of HIF-1. The Journal of Biological Chemistry, 2003; 278: 1802-1806. | |
| |
60. Dann C.E.III., Bruick R.K., Deisenhofer J. Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway. Proceedings of the National Academy of Sciences of the U.S.A., 2002; 99: 15351-15356. | |
| |
61. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nature Reviews Molecular Cell Biology, 2004; 5: 343-354. | |
| |
62. Peyssonnaux C., Nizet V., Johnson R.S. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle, 2008; 7(1): 28-32. | |
| |
63. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A. et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). Journal of Clinical Investigations, 2007; 117(7): 1926-1932. | |
| |
64. Bentovim L., Amarilio R., Zelzer E. HIF1α is a central regulator of collagen hydroxylation and secretion under hypoxia during bone development. Development, 2012; 139(23): 4473-4483. | |
| |
65. Cicchillitti L., Di Stefano V., Isaia E. et al. Hypoxia-inducible factor 1-α induces miR-210 in normoxic differentiating myoblasts. The Journal of Biological Chemistry, 2012; 287(53): 44761-44771. | |
| |
66. Ratcliffe P.J., O'Rourke J.F., Maxwell P.H., Pugh C.W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. Journal of Experimental Biology, 1998; 201: 1153-1162. | |
| |
67. Minchenko O., Opentanova I., Caro J. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Letters, 2003; 554(3): 264-270. | |
| |
68. Minchenko A., Bauer T., Salceda S., Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Laboratory Investigation, 1994; 71(3): 374-379. | |
| |
69. Mueller M.D., Vigne J.-L., Minchenko A.G. et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors "a" and "b". Proceedings of the National Academy of Sciences of the U.S.A., 2000; 97(20): 10972-10977. | |
| |
70. Aversa C.R., Oparil S., Caro J. et al. Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. American Journal Physiology, 1997; 273 (4 Pt 1): L848-L855. | |
| |
71. Minchenko O.H., Ochiai A., Opentanova I.L. et al. Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. Biochimie, 2005; 87(11): 1005-1010. | |
| |
72. Erpolat O.P., Gocun P.U., Akmansu M. et al. Hypoxia-related molecules HIF-1α, CA9, and osteopontin: Predictors of survival in patients with high-grade glioma. Strahlenther Onkology, 2013; 189(2): 147-154. | |
| |
73. Weidemann A., Johnson R.S. Biology of HIF-1alpha. Cell Death & Differentiation, 2008; 15(4): 621-627. | |
| |
74. He Y., Kim H., Ryu T. et al. δ-catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF. FEBS Letters, 2013; 587(2): 193-199. | |
| |
75. Denko N.C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews Cancer, 2008; 8: 705-713. | |
| |
76. Rankin E.B., Rha J., Unger T.L. et al. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene, 2008; 27(40): 5354-5358. | |
| |
77. Azar R., Lasfargues C., Bousquet C., Pyronnet S. Contribution of HIF-1α in 4E-BP1 Gene Expression. Molecular Cancer Research, 2013; 11(1): 54-61. | |
| |
78. Johnson A.B., Denko N., Barton M.C. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutation Research, 2008; 640: 174-179. | |
| |
79. Carmeliet P., Dor Y., Herbert J.M. et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 1998; 394(6692): 485-490. | |
| |
80. Semenza G.L. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discovery Today, 2007; 12: 853-859. | |
| |
81. Chen J., Zhao S., Nakada K. et al. Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. American Journal of Pathology, 2003; 162(4): 1283-1291. | |
| |
82. Shojaei F., Ferrara N. Antiangiogenic therapy for cancer: an update. Cancer Journal, 2007; 13(6): 345-348. | |
| |
83. Minchenko D.O., Bobarykina A.Y., Ratushna O.O. et al. Dominant-negative constructs of human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 and -4: effect on the expression of endogenous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA. Biotechnology, 2008; 1(4): 49-56. | |
| |
84. Zheng X., Linke S., Dias J.M. et al. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proceedings of the National Academy of Sciences of the U.S.A., 2008; 105: 3368-3373. | |
| |
85. Patel S.A., Simon M.C. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death & Differentiation, 2008; 15(4): 628-634. | |
| |
86. Bertout J.A., Patel S. A., Fryer B.H. et al. Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. Cancer Research, 2009; 69: 3213-3220. | |
| |
87. Chen C., Cai S., Wang G. et al. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α. Biochemical and Biophysical Research Commununications, 2013; 430(2): 505-511. | |
| |
88. Laderoute K.R., Calaoagan J.M., Knapp M., Johnson R.S. Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun. Molecular and Cellular Biology, 2004; 24(10): 4128-4137. | |
| |
89. Cockman M.E., Lancaster D.E., Stolze I.P. et al. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proceedings of the National Academy of Sciences of the U.S.A., 2006; 103: 14767-14772. | |
| |
90. Van Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1α by NF-κB. Biochemical Journal, 2008; 381: 477-484. | |
| |
91. Kaelin W.G. Jr. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nature Reviews Cancer, 2008; 8: 865-872. | |
| |
92. Boutin A.T., Weidemann A., Fu Z. et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell, 2008; 133(2): 223-234. | |
| |
93. Kapitsinou P.P., Haase V.H. The VHL tumor suppressor and HIF: insights from genetic studies in mice. Cell Death & Differentiation, 2008; 15(4): 650-659. | |
| |
94. Lei L., Mason S., Liu D. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Molecular and Cellular Biology, 2008; 28(11): 3790-3803. | |
| |
95. Baek J.H., Liu Y.V., McDonald K.R. et al. Spermidine/spermine N1-acetyltransferase-1 binds to hypoxia-inducible factor-1a (HIF-1a) and RACK1 and promotes ubiquitination and degradation of HIF-1a. The Journal of Biological Chemistry, 2007; 282: 33358-33366. | |
| |
96. Ock M.S., Song K.S., Kleinman H., Cha H.J. Thymosin β4 stabilizes hypoxia-inducible factor-1α protein in an oxygen-independent manner. Annals of the New York Academy of Sciences, 2012; 1269: 79-83. | |
| |
97. Li M., Liu Y., Jin F. et al. Endothelin-1 induces hypoxia inducible factor 1α expression in pulmonary artery smooth muscle cells. FEBS Letters, 2012; 586(21): 3888-3893. | |
| |
98. Kumar S., Mehta K. Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway. PLoS One, 2012; 7(11): e49321. | |
| |
99. Wouters B.G., Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews Cancer, 2008; 8: 851-762. | |
Refbacks
- There are currently no refbacks.
Copyright (c) 2013 Studia biologica
This work is licensed under a Creative Commons Attribution 4.0 International License.